{"doi":"10.1016/j.jval.2018.07.801","title":"Risk of Severe Adverse Reactions Related to Allopurinol and Febuxostat in Asians","abstract":null,"journal":"Value in Health","year":2018,"id":651346,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1698622,"name":"W Chung","orcid":null,"position":1,"is_corresponding":false},{"id":1698623,"name":"YJ Lin","orcid":null,"position":2,"is_corresponding":false},{"id":53743,"name":"C Chang","orcid":null,"position":3,"is_corresponding":false},{"id":415735,"name":"S Chang","orcid":"0000-0002-9091-1742","position":4,"is_corresponding":false},{"id":117863,"name":"C Chen","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Risk of Severe Adverse Reactions Related to Allopurinol and Febuxostat in Asians","abstract":null,"is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19965766","pmcid":null,"openalex_id":"https://openalex.org/W2900321081","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.11627907,"influential_citations":0,"citation_trend":[{"year":2023,"count":1},{"year":2024,"count":1}],"oa_status":"bronze","license":"http://www.elsevier.com/open-access/userlicense/1.0/","oa_locations":[{"url":"http://www.valueinhealthjournal.com/article/S1098301518331589/pdf","host_type":"journal"},{"url":"http://www.valueinhealthjournal.com/article/S1098301518331589/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1098301518331589?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1098301518331589?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.jval.2018.07.801","host_type":"journal"}],"fields_of_study":["Drug-Induced Adverse Reactions","Urticaria and Related Conditions","Eosinophilic Disorders and Syndromes"],"mesh_terms":[],"keywords":["Febuxostat","Allopurinol","Medicine","Toxic epidermal necrolysis","Gout","Hyperuricemia","Incidence (geometry)","Adverse effect","Internal medicine","Dermatology","Pharmacology","Uric acid"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-10T07:49:46.022616Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}